Wellbiotec Co., Ltd. (010600.KS) KSC

545.00

+545(+100.00%)

Updated at June 04 06:00PM

Currency In KRW

Valuation

Market Cap48.05B
Enterprise Value42.5B
P/E Ratio-2.68
PEG Ratio-0.4
Price/Sales Ratio0.6
Price/Book Ratio2.9
Enterprise/Revenue0.55
Enterprise/EBITDA-4.7

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.23
Operating Margin-0.01

Management Effectiveness

Return On Assets-0.69
Return On Equity-0.88

Income Statement

Revenue83.3B
Revenue/Share896.83
Gross Profit9.7B
EBITDA-15.99B
Net Income-21.22B
Diluted EPS-267.94

Balance Sheet

Total Cash6.5B
Total Cash/Share70.38
Total Debt1.41B
Total Debt/Equity0.08
Current Ratio2.1
Book Value Per Share188.14

Price History

52-Week Change0
52-Week High545
52-Week Low545
Moving Average 50 Days545
Moving Average 200 Days545

Statistics

Average Volume0
Shares Outstanding90.92M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateNovember 22, 2011